Vitamin E

( DrugBank: Vitamin E / KEGG DRUG: Vitamin E )


5 diseases
IDDisease name (Link within this page)Number of trials
2Amyotrophic lateral sclerosis2
19Lysosomal storage disease1
20Adrenoleukodystrophy1
IDDisease name (Link within this page)Number of trials
90Retinitis pigmentosa1
206Fragile X syndrome2

2. Amyotrophic lateral sclerosis


Clinical trials : 786Drugs : 550 - (DrugBank : 182) / Drug target genes : 170 - Drug target pathways : 232 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

19. Lysosomal storage disease


Clinical trials : 990Drugs : 584 - (DrugBank : 126) / Drug target genes : 62 - Drug target pathways : 192 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

20. Adrenoleukodystrophy


Clinical trials : 68Drugs : 74 - (DrugBank : 32) / Drug target genes : 25 - Drug target pathways : 131 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

90. Retinitis pigmentosa


Clinical trials : 186Drugs : 191 - (DrugBank : 52) / Drug target genes : 43 - Drug target pathways : 87 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

206. Fragile X syndrome


Clinical trials : 118Drugs : 75 - (DrugBank : 30) / Drug target genes : 58 - Drug target pathways : 83 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries